Cargando…

Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis

To date, there have been multiple studies and clinical guidelines or recommendations for complex management of melanoma patients. The most controversial subjects included the frequency of follow-up. This study provides a coherent and comprehensive comparison of conventional vs. reduced-frequency fol...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Karolina, Stefura, Tomasz, Kłos, Nikola, Tempski, Jonasz, Kołodziej-Rzepa, Marta, Kisielewski, Michał, Wojewoda, Tomasz, Wysocki, Wojciech M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046891/
https://www.ncbi.nlm.nih.gov/pubmed/36975469
http://dx.doi.org/10.3390/curroncol30030256
_version_ 1785013785582370816
author Richter, Karolina
Stefura, Tomasz
Kłos, Nikola
Tempski, Jonasz
Kołodziej-Rzepa, Marta
Kisielewski, Michał
Wojewoda, Tomasz
Wysocki, Wojciech M.
author_facet Richter, Karolina
Stefura, Tomasz
Kłos, Nikola
Tempski, Jonasz
Kołodziej-Rzepa, Marta
Kisielewski, Michał
Wojewoda, Tomasz
Wysocki, Wojciech M.
author_sort Richter, Karolina
collection PubMed
description To date, there have been multiple studies and clinical guidelines or recommendations for complex management of melanoma patients. The most controversial subjects included the frequency of follow-up. This study provides a coherent and comprehensive comparison of conventional vs. reduced-frequency follow-up strategies for early-stage melanoma patients. The value of our study consists in the precise analysis of a large collection of articles and the selection of the most valuable works in relation to the topic according to rigorous criteria, which allowed for a thorough study of the topic. The search strategy was implemented using multiple databases. The inclusion criteria were randomized clinical trial or cohort studies that compared the outcomes of a conventional follow-up schedule versus a reduced-frequency follow-up schedule for patients diagnosed with melanoma. In this study, authors analyzed recurrence and 3-year survival. Meta-analysis of outcomes presented by Deckers et al. and Moncrieff et. al. did not reveal a significant difference favoring one of the groups (OR 1.14; 95%CI: 0.65–2.00; p = 0.64). The meta-analysis of 3-year overall survival included two studies. The statistical analysis showed no significant difference in favor of the conventional follow-up group. (OR 1.10; 95%CI: 0.57–2.11; p = 0.79). Our meta-analysis shows that there is no advantage in a conventional follow-up regimen over a reduced-frequency regimen in early-stage melanoma patients.
format Online
Article
Text
id pubmed-10046891
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100468912023-03-29 Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis Richter, Karolina Stefura, Tomasz Kłos, Nikola Tempski, Jonasz Kołodziej-Rzepa, Marta Kisielewski, Michał Wojewoda, Tomasz Wysocki, Wojciech M. Curr Oncol Communication To date, there have been multiple studies and clinical guidelines or recommendations for complex management of melanoma patients. The most controversial subjects included the frequency of follow-up. This study provides a coherent and comprehensive comparison of conventional vs. reduced-frequency follow-up strategies for early-stage melanoma patients. The value of our study consists in the precise analysis of a large collection of articles and the selection of the most valuable works in relation to the topic according to rigorous criteria, which allowed for a thorough study of the topic. The search strategy was implemented using multiple databases. The inclusion criteria were randomized clinical trial or cohort studies that compared the outcomes of a conventional follow-up schedule versus a reduced-frequency follow-up schedule for patients diagnosed with melanoma. In this study, authors analyzed recurrence and 3-year survival. Meta-analysis of outcomes presented by Deckers et al. and Moncrieff et. al. did not reveal a significant difference favoring one of the groups (OR 1.14; 95%CI: 0.65–2.00; p = 0.64). The meta-analysis of 3-year overall survival included two studies. The statistical analysis showed no significant difference in favor of the conventional follow-up group. (OR 1.10; 95%CI: 0.57–2.11; p = 0.79). Our meta-analysis shows that there is no advantage in a conventional follow-up regimen over a reduced-frequency regimen in early-stage melanoma patients. MDPI 2023-03-14 /pmc/articles/PMC10046891/ /pubmed/36975469 http://dx.doi.org/10.3390/curroncol30030256 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Communication
Richter, Karolina
Stefura, Tomasz
Kłos, Nikola
Tempski, Jonasz
Kołodziej-Rzepa, Marta
Kisielewski, Michał
Wojewoda, Tomasz
Wysocki, Wojciech M.
Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis
title Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis
title_full Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis
title_fullStr Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis
title_full_unstemmed Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis
title_short Conventional versus Reduced-Frequency Follow-Up in Early-Stage Melanoma Survivors: A Systematic Review with Meta-Analysis
title_sort conventional versus reduced-frequency follow-up in early-stage melanoma survivors: a systematic review with meta-analysis
topic Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046891/
https://www.ncbi.nlm.nih.gov/pubmed/36975469
http://dx.doi.org/10.3390/curroncol30030256
work_keys_str_mv AT richterkarolina conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis
AT stefuratomasz conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis
AT kłosnikola conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis
AT tempskijonasz conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis
AT kołodziejrzepamarta conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis
AT kisielewskimichał conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis
AT wojewodatomasz conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis
AT wysockiwojciechm conventionalversusreducedfrequencyfollowupinearlystagemelanomasurvivorsasystematicreviewwithmetaanalysis